| Literature DB >> 23109914 |
Carla Makhlouf Obermeyer1, Melissa Neuman, Alice Desclaux, Rhoda Wanyenze, Odette Ky-Zerbo, Peter Cherutich, Ireen Namakhoma, Anita Hardon.
Abstract
BACKGROUND: Recommendations about scaling up HIV testing and counseling highlight the need to provide key services and to protect clients' rights, but it is unclear to what extent different modes of testing differ in this respect. This paper examines whether practices regarding consent, confidentiality, and referral vary depending on whether testing is provided through voluntary counseling and testing (VCT) or provider-initiated testing. METHODS ANDEntities:
Mesh:
Year: 2012 PMID: 23109914 PMCID: PMC3479110 DOI: 10.1371/journal.pmed.1001329
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Percent respondents reporting on outcome measures of HIV testing, by country and mode of testing.
| Country | Outcome Measure | Integrated (Percent) | VCT (Percent) | PMTCT (Percent) | Total ( | Total (Percent Yes) | χ2(2) |
|
|
| Pre-test: meet with counselor | 83.3 | 95.3 | 92.3 | 1,875 | 89 | 66.18 | <0.001 |
| Pre-test index: all items | 78.6 | 73.1 | 72.3 | 1,410 | 75.4 | 8.38 | 0.015 | |
| Consent index: all items | 89.7 | 83.4 | 82.9 | 1,611 | 86.1 | 16.51 | <0.001 | |
| Post-test: received results | 98.6 | 100 | 99 | 1,997 | 99.1 | 9.04 | 0.011 | |
| Post-test index: all items | 58.7 | 35.8 | 59 | 1,015 | 51.5 | 90.25 | <0.001 | |
| Confidentiality index: all items | 81.6 | 77 | 77.6 | 1,451 | 79.2 | 5.34 | 0.069 | |
| Referral index | 73.7 | 66.2 | 63.3 | 393 | 70.6 | 4.52 | 0.105 | |
| Satisfaction index: all items | 80.2 | 79.9 | 83 | 1,647 | 80.7 | 1.78 | 0.411 | |
|
| Pre-test: meet with counselor | 67.4 | 96.3 | 96.2 | 538 | 88.8 | 86.24 | <0.001 |
| Pre-test index: all items | 45.7 | 62.4 | 40.2 | 476 | 54.4 | 18.43 | <0.001 | |
| Consent index: all items | 77.2 | 74.8 | 83.3 | 476 | 77.1 | 3.07 | 0.215 | |
| Post-test: received results | 95.6 | 100 | 100 | 537 | 98.9 | 17.72 | <0.001 | |
| Post-test index: all items | 7.8 | 15.1 | 14.2 | 525 | 13.1 | 4.28 | 0.118 | |
| Confidentiality index: all items | 75 | 77.4 | 64.4 | 463 | 74.1 | 6.56 | 0.038 | |
| Referral index | 63.8 | 50.8 | 83.3 | 114 | 57.9 | 3.52 | 0.172 | |
| Satisfaction index: all items | 62.1 | 77.0 | 77.1 | 516 | 73.4 | 10.79 | 0.005 | |
|
| Pre-test: meet with counselor | 97 | 97 | 92.4 | 376 | 96 | 3.39 | 0.183 |
| Pre-test index: all items | 82.8 | 75 | 82.2 | 361 | 82 | 1.18 | 0.555 | |
| Consent index: all items | 95.3 | 93.8 | 90.4 | 361 | 94.2 | 2.50 | 0.286 | |
| Post-test: received results | 99.2 | 100 | 100 | 376 | 92.4 | 0.86 | 0.649 | |
| Post-test index: all items | 79.1 | 68.8 | 82.1 | 363 | 78.8 | 2.44 | 0.296 | |
| Confidentiality index: all items | 78.8 | 72.7 | 74 | 356 | 77.2 | 1.17 | 0.557 | |
| Referral index | 81.4 | 77.8 | 87.5 | 130 | 81.5 | 0.27 | 0.872 | |
| Satisfaction index: all items | 83.1 | 87.5 | 88.6 | 366 | 84.7 | 1.60 | 0.448 | |
|
| Pre-test: meet with counselor | 87 | 97.7 | 91.4 | 529 | 89 | 5.49 | 0.064 |
| Pre-test index: all items | 92.1 | 90.5 | 89 | 471 | 91.1 | 1.06 | 0.588 | |
| Consent index: all items | 94.4 | 88.1 | 88.2 | 471 | 92.1 | 5.76 | 0.056 | |
| Post-test: received results | 99.4 | 100 | 99.3 | 524 | 93.3 | 0.30 | 0.860 | |
| Post-test index: all items | 71.2 | 53.5 | 75.2 | 517 | 70.8 | 7.53 | 0.023 | |
| Confidentiality index: all items | 94.9 | 85.7 | 92 | 462 | 93.3 | 5.43 | 0.066 | |
| Referral index | 66.2 | 57.1 | 56.3 | 175 | 64 | 1.26 | 0.533 | |
| Satisfaction index: all items | 95.3 | 90.7 | 93.5 | 520 | 94.4 | 1.84 | 0.398 | |
|
| Pre-test: meet with counselor | 72.7 | 93.9 | 89.4 | 664 | 85.1 | 51.97 | <0.001 |
| Pre-test index: all items | 67.2 | 80.8 | 77.4 | 562 | 75.8 | 11.62 | 0.003 | |
| Consent index: all items | 80.6 | 89.8 | 67.5 | 563 | 83.5 | 25.02 | <0.001 | |
| Post-test: received results | 98.2 | 100 | 96.6 | 578 | 98.8 | 7.23 | 0.027 | |
| Post-test index: all items | 45.9 | 52.1 | 67.4 | 565 | 52 | 11.48 | 0.003 | |
| Confidentiality index: all items | 67.0 | 75.8 | 75.3 | 552 | 72.8 | 4.61 | 0.100 | |
| Referral index | 86.0 | 78.4 | 57.1 | 138 | 79 | 5.52 | 0.063 | |
| Satisfaction index: all items | 65.0 | 80.4 | 68.5 | 640 | 73 | 17.29 | <0.001 |
Includes only HIV-positive respondents.
Remains significantly less than 0.05 after correction for false discovery rate.
Prevalence ratios for outcome measures, by country and mode of testing.
| Outcome Measure | Adjusted Prevalence Ratio (95% CI) | ||||
| All Countries | Burkina Faso | Kenya | Malawi | Uganda | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.22 | 1.45 | 0.90 | 1.11 | 1.25 |
| (1.07–1.38) | (0.94–2.22) | (0.72–1.12) | (1.05–1.18) | (1.04–1.51) | |
| PMTCT | 1.09 | 1.41 | 0.97 | 1.03 | 1.17 |
| (1.00–1.20) | (0.93–2.13) | (0.85–1.10) | (0.96–1.09) | (0.93–1.47) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.15 | 1.34 | 0.90 | 0.97 | 1.18 |
| (0.99–1.33) | (0.86–2.10) | (0.72–1.12) | (0.85–1.10) | (0.97–1.44) | |
| PMTCT | 0.98 | 0.88 | 0.97 | 0.96 | 1.15 |
| (0.88–1.09) | (0.59–1.31) | (0.85–1.10) | (0.87–1.06) | (0.91–1.45) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.03 | 1.01 | 1.00 | 0.94 | 1.1 |
| (0.95–1.12) | (0.82–1.24) | (0.93–1.08) | (0.88–1.01) | (0.96–1.27) | |
| PMTCT | 0.95 | 1.08 | 0.94 | 0.93 | 0.86 |
| (0.89–1.02) | (0.89–1.31) | (0.82–1.09) | (0.87–1.00) | (0.66–1.11) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.02 | 1.05 | 1.00 | 1.01 | 1.02 |
| (1.00–1.04) | (0.99–1.10) | (1.00–1.01) | (1.00–1.03) | (1.00–1.04) | |
| PMTCT | 1.00 | 1.04 | 1.00 | 0.99 | 0.98 |
| (0.99–1.01) | (0.99–1.08) | (0.99–1.00) | (0.98–1.01) | (0.95–1.02) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.00 | 1.93 | 0.91 | 0.78 | 1.05 |
| (0.83–1.20) | (0.90–4.10) | (0.69–1.21) | (0.59–1.03) | (0.86–1.28) | |
| PMTCT | 1.09 | 1.87 | 1.04 | 1.00 | 1.40 |
| (0.94–1.27) | (0.83–4.24) | (0.91–1.20) | (0.85–1.17) | (1.01–1.94) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.04 | 1.02 | 0.99 | 0.91 | 1.13 |
| (0.97–1.11) | (0.90–1.15) | (0.82–1.18) | (0.79–1.05) | (1.04–1.23) | |
| PMTCT | 0.97 | 0.88 | 0.94 | 0.97 | 1.14 |
| (0.90–1.06) | (0.76–1.02) | (0.71–1.26) | (0.91–1.03) | (0.96–1.36) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 0.87 | 0.76 | 0.90 | 0.84 | 0.91 |
| (0.74–1.02) | (0.50–1.16) | (0.78–1.04) | (0.57–1.22) | (0.78–1.07) | |
| PMTCT | 0.89 | 1.56 | 0.88 | 0.89 | 0.71 |
| (0.73–1.08) | (0.87–2.78) | (0.64–1.20) | (0.62–1.26) | (0.57–0.89) | |
|
| |||||
| Integrated testing | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Stand-alone VCT | 1.15 | 1.28 | 1.02 | 0.97 | 1.23 |
| (1.06–1.25) | (1.10–1.48) | (0.87–1.21) | (0.88–1.06) | (1.10–1.37) | |
| PMTCT | 1.05 | 1.19 | 1.06 | 0.97 | 1.07 |
| (0.98–1.13) | (1.03–1.38) | (0.92–1.22) | (0.92–1.03) | (0.80–1.43) | |
All models adjusted for respondent sex, age (in years), educational attainment, and wealth index, and adjusted for clustered sampling using a generalized estimating equation. All countries model also adjusted for country using fixed effect.
p-Value remains significantly less than 0.05 after correction for false discovery rate.
Includes only HIV-positive respondents.